Previous Speakers

Gerald C Hsu

eclaireMD Foundation,USA USA

Shirley Mcilvenny

Food Coach Institute, Australia Australia

Joseph M Pappachan

University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom UK

Grant Brinkworth

Commonwealth Scientific and Industrial Research Organisation, Australia Australia

Magdy El-Salhy

University of Bergen, Norway Norway

Amer Kamal Al Ansari

Utrecht University, Netherlands Netherlands

Emilio Galea

Urgo International, United Arab Emirates United Arab Emirates

Irina Kurnikova

RUDN University, Russia Russia

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Europe & UK

Global Diabetes 2025, France Euro Diabetes 2025, UK

Asia Pacific & Middle East

Canada

Diabetes Meeting 2025, Canada

Diabetes Asia Pacific 2019

About Conference

Conference Series invites the worldwide global audience and presenters to participate at the 21^stAsia Pacific Diabetes Conference which is to be held in Sydney, Australia during July 29-30, 2019.

Special interest and theme of the conference is “Lifestyle modifications and Management strategies for the prevention of diabetes”.

Diabetes is a disease in which the body is unable to properly use and store glucose (a form of sugar). Glucose backs up in the bloodstream — causing one’s blood glucose (sometimes referred to as blood sugar) to rise too high.

There are two major types of diabetes. In type 1 (formerly called juvenile-onset or insulin-dependent) diabetes, the body completely stops producing any insulin, a hormone that enables the body to use glucose found in foods for energy. People with type 1 diabetes must take daily insulin injections to survive. This form of diabetes usually develops in children or young adults, but can occur at any age. Type 2 (formerly called adult-onset or non-insulin-dependent) diabetes results when the body doesn’t produce enough insulin and/or is unable to use insulin properly (insulin resistance). This form of diabetes usually occurs in people who are over 40, overweight, and have a family history of diabetes, although today it is increasingly occurring in younger people, particularly adolescents.

Diabetes Asia Pacific 2019 aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. The meeting gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.This conference is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Asia Pacific 2019 is where the future of management and novel therapeutics for the disease intersects.

Conference Series llc LTD organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members

Why to attend?

Diabetes Asia Pacific 2019 highlights the theme “Lifestyle modifications and Management strategies for the prevention of diabetes” Which emphasis on the latest advancements in prevention and treatment cure of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Endocrine Complications..

Target Audience:

Endocrinologists
Diabetologists
Researchers
Practitioners/Doctors
Students
Nurse educator
Podiatrist
Dietitian
Eye Doctors
Nephrologists
Physical trainer or Exercise physiologist

Tracks/Sessions

Track 1: Diabetes Diagnostics and Therapeutics

The incidence rate of diabetes is exceptionally high across the globe, fuelled by reducing physical activities and unhealthy diet. According to IMARC’s report, compared to Type-1 diabetes, Type-2 diabetes represents the more prevalent type, accounting for the majority of all diagnosed diabetes cases. Urban areas dominate rural areas in the number of diabetes patients and females presently account for the majority of the total diabetes patients. Despite the general down climate of the economy and healthcare, there has been great progress in the advancement of diabetes knowledge, treatment and prevention in recent years. This progress continues of a daily basis, with scientific advances being announced at an exponential rate. New therapeutic products are being introduced regularly and the pipeline is now full of new diabetes therapeutics in development. Never before, in the history of medicine, has the outlook for diabetes treatment and prevention looked so promising. The diabetes drugs segment dominated the endocrinology drugs market and accounted for more than 86% of the market share during 2015. At an annual growth rate (CAGR) of 4.4%, from 2016 to 2021, World diabetes market projected to reach $155 billion by 2021 from $125 billion. Follow Endocrinology Conferences and Diabetes Conferences for more updates.

Insulin secretagogues
Insulin sensitizers
Diabetes therapy
Glucose absorption inhibitors(Sodium–Glucose Co-Transporter (SGLT-1 and 2) Inhibitors)
Glucagon-Like Peptide-1 (GLP-1) analogues (Lixisenatide)
Dipeptidyl Peptidase-IV (DPP IV) Inhibitors
Novel lyophilized hydrogel patches (Convenient insulin administration)
Glucokinase Activators
Insulin analogues & Insulin pumps

Related Conferences:

13th International Conference on Endocrinology Diabetes and Metabolism April 08-09, 2019 Wellington, New Zealand, 12th World Congress on Endocrinology and Metabolic Disorders May 13-14th, 2019 Osaka, Japan , 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey , 21st Asia Pacific Diabetes Conference July 29-30, 2019 Perth, Australia , 4th International Conference & Exhibition on Metabolic Syndrome June 20-21, 2019 Paris, France, 18th Global Conference on Diabetes and Nursing Care June 27-28, 2019 Amsterdam, Netherlands, 12th World Congress on Diabetes, Endocrinology and Nursing July 05-06, 2019 Columbus, USA , 28th European Diabetes Congress July 17-18, 2019 Edinburgh, Scotland , 27th International Diabetes and Healthcare Conference July 18-19, 2019 Abu Dhabi, UAE

Track 2: Genetics and Gene Regulation

Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes the majority of genetic risk of diabetes remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies.

Diabetes Hereditary
Diet
Obesity
Metabolic Syndrome
Insulin Resistance
Measles

Related Conferences:

29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia , 12th International Conference on Diabetes & Metabolism September 18-19, 2019San Francisco, USA , 31st International Conference on Pediatrics & Adolescent Diabetes August 12-13, 2019 Tokyo, Japan , 15th World Congress on Endocrinology & Diabetes September 20-21, 2019Prague, Czech Republic , Euro Diabetes Congress & Expo September 21-22, 2019 | Prague, Czech Republic , Global congress on Endocrinology and Gynecology October 14-15, 2019 Sydney, Australia, 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland , International Conference on Diabetes and Cholesterol Metabolism November 25-26, 2019 Dubai, UAE , Global Summit On Diabetes & Endocrinology November 25-26, 2019 Yokohama, Japan , 14th European Diabetes and Endocrinology Congress December 02-03, 2019 |Barcelona, Spain , 3rd Annual Congress on Diabetes and Its Complications December 04-05, 2019 Tokyo, Japan

Track 3: Risk Factors and Related Diseases of Diabetes

Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.

Diabetic Cardiomyopathy
Diabetic Retinopathy
Prediabetes
Increased thirst
Frequent urination
Extreme hunger
Unexplained weight loss

Related Conferences:

Track 4: Pathophysiology Of Endocrine Glands And Hormones

Endocrine disorders can be classified according to the intensity of hormonal activity and according to the origin of endocrine disorder. From the intensity of hormonal activity of endocrine gland we can distinguish hyper function of endocrine gland, which is characterized by increased secretion of its hormone as well as by increased concentration of this hormone in circulating blood. If endocrine gland produces several kinds of hormones the symptoms resulting from hyper production or hypo production of more kinds of hormones may develop, respectively, at the same time the symptoms of hyper function resulting from overproduction of one kind of hormones and the symptoms of hypo function due to a deficiency of other kind of hormones can develop. Refunction of endocrine gland, which is in the time of medical examination characterized by normal secretion of its hormone as well as by normal concentration of this hormone in circulating blood. Endocrine disease results when a gland produces too much or too little of an endocrine hormone called as hormone imbalance.

Hormones and diabetes complications
Thyroid and thymus
Thyroid and thymus
Pituitary and pineal glands
Primary aldosterone’s
Pheochromocytoma
Hyperprolactinemia
Pituitary and pineal glands

Related Conferences:

Track 5: Diabetic Surgeries

Diabetes mellitus type 2 is an epidemic health problem, affecting more than 150 million people worldwide. This number is expected to double in the first decades of the third millennium. Recently, evidence for reduction of complications of type 2 diabetes with tight control of hyperglycaemia has been reported, but current therapies, including diet, exercise, behaviour modification, oral hypoglycaemic agents, and insulin, rarely return patients to euglycemia. Morbid obesity, in which patients exceed their ideal weight by at least 100 lb or are more than 200% of ideal body weight, is a condition with high mortality and morbidity because of its association with severe comorbid diseases such as hypertension, diabetes, hyperlipidaemia, and cardiopulmonary failure. In these patients, surgery represents the most effective therapy in that it achieves significant and durable weight loss as well as resolution or amelioration of comorbidities. Current indications for surgery in morbidly obese patients include body mass index (BMI) greater than 40 or greater than 35 if comorbidities are present.

Bariatric surgeries
Metabolic surgeries
Sleeve gastrectomy
Vascular Surgery

Related Conferences:

Track 6: Clinical Research And Case Studies

A clinical trial is an approach to precisely test another medication or gadget in patients before it is endorsed by the FDA to be utilized in public. Clinical trials are an important and critical step in our having the capacity to have new medications for diabetes and other varied conditions. A case study is a methodology and a strategy that investigates a phenomenon with its real-life context. Case studies and clinical trials are used to develop or assess the quality of the medications being developed.

Clinical diagnosis and laboratory tests
Diabetes, Prediabetes and Metabolic Syndrome
Clinical trials on animal models
Novel research and treatment strategies on diabetes
Clinical case reports and clinical endocrinology practices
Novel Paradigms in Diabetic Complications
Clinical presentation and diagnosis of diabetes mellitus in adults

Related Conferences:

Track 7: Diabetic Nutrition & Physical Fitness

Diet and physical fitness are imperative parts of a sound way of life when you have diabetes. Alongside different advantages, following a healthy balanced diet and being dynamic can enable you to keep your blood glucose level in your objective range. To deal with your blood glucose, you must adjust with what you eat and drink along with physical movement and medications. The quantity and quality of food that you eat, and when you eat are extremely vital in keeping your blood glucose level in the range that your healthcare professional suggests.

Exercise for diabetics
Diet for Diabetics
Nutrition for Diabetics
Protein intake and Diabetes
Food combinations and diabetes
Lifestyle Intervention and Diabetes Prevention

Related Conferences:

World Congress on Endocrinology & Diabetes September 20-21, 2019Prague, Czech Republic , Euro Diabetes Congress & Expo September 21-22, 2019 | Prague, Czech Republic , Global congress on Endocrinology and Gynecology October 14-15, 2019 Sydney, Australia, 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland , International Conference on Diabetes and Cholesterol Metabolism November 25-26, 2019 Dubai, UAE , Global Summit On Diabetes & Endocrinology November 25-26, 2019 Yokohama, Japan , 14th European Diabetes and Endocrinology Congress December 02-03, 2019 |Barcelona, Spain , 3rd Annual Congress on Diabetes and Its Complications December 04-05, 2019 Tokyo, Japan

Track 8 : Gestational diabetes

Gestational diabetes is diabetes that occurs during pregnancy in women. Gestational diabetes occurs in about 4% of all pregnancies. It is usually diagnosed at any stages of pregnancy but is more common in the second half and occurs in women who have no prior history of diabetes. In most cases Gestational diabetes is picked up when blood sugar level is tested during screening. Some women may develop symptoms if their blood sugar level becomes too high. This may lead to difficulties during the delivery and increases the chances of needing a caesarean section. Follow Diabetes Conferences for more details

Placental Hormones
Genetics of Diabetes
Prediabetes
Etiology and pathogenesis
Managing self-care
Prognosis
Monitoring fatal growth and well-being

Related Conferences:

21st Asia Pacific Diabetes Conference July 29-30, 2019 Perth, Australia , 4th International Conference & Exhibition on Metabolic Syndrome June 20-21, 2019 Paris, France, 18th Global Conference on Diabetes and Nursing Care June 27-28, 2019 Amsterdam, Netherlands, 12th World Congress on Diabetes, Endocrinology and Nursing July 05-06, 2019 Columbus, USA , 28th European Diabetes Congress July 17-18, 2019 Edinburgh, Scotland , 27th International Diabetes and Healthcare Conference July 18-19, 2019 Abu Dhabi, UAE,29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia , 12th International Conference on Diabetes & Metabolism September 18-19, 2019San Francisco, USA , 31st International Conference on Pediatrics & Adolescent Diabetes August 12-13, 2019 Tokyo, Japan.

Track 9 : Emerging Focus in Diabetes Research

Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidaemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidaemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned.

Diabetes Research
Diabetes and cancer
Obesity
Type 1 Diabetes
Type 2 Diabetes
Diabetic dyslipidaemia

Related Conferences:

13th International Conference on Endocrinology Diabetes and Metabolism April 08-09, 2019 Wellington, New Zealand, 12th World Congress on Endocrinology and Metabolic Disorders May 13-14th, 2019 Osaka, Japan , 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey, 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia , 12th International Conference on Diabetes & Metabolism September 18-19, 2019San Francisco, USA , 31st International Conference on Pediatrics & Adolescent Diabetes August 12-13, 2019 Tokyo, Japan , 15th World Congress on Endocrinology & Diabetes September 20-21, 2019Prague, Czech Republic , Euro Diabetes Congress & Expo September 21-22, 2019 | Prague, Czech Republic

Track 10 :Stem Cell treatment for Type 2 Diabetes

In every of these cases, using one's own stem cells will facilitate the exocrine gland regenerate and boost its ability to produce insulin. Procedure continues to achieve success, with patients experiencing health advantages even six months after stem cell diabetes treatment. repeated applications of adipose stem cells is that the most effective treatment for diabetes type two, providing an open window to create dietary changes, supplementation and exercise much more effective for long-term management of blood glucose. Adult stem cells, undifferentiated and adaptable, area unit ready to transform into the cells of innumerable organs and structures inside the body.

Swiss Medical Clinic has developed the Adult autologous stem cell medical care program to treat a range of conditions. Throughout stem cell treatment a patient receives 200 – 300 million stem cells. The number of restored cells not only covers daily losses, however exceeds them 1000 times. Thus, the reserve of the stem cells, much lost for the newest 15 – 20 years, is restored. When such active cell filling, organ gets rejuvenated and revived, because the new and active cells displace the previous and broken ones.

Stem Cell Therapy
Treatment of Diabetes
Embryonic Stem Cell Research
Type 1 Diabetes Beta Cells
Umbilical Stem Cells
Stem Cells and Diabetes

Related Conferences:

Global congress on Endocrinology and Gynecology October 14-15, 2019 Sydney, Australia, 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland , International Conference on Diabetes and Cholesterol Metabolism November 25-26, 2019 Dubai, UAE , Global Summit On Diabetes & Endocrinology November 25-26, 2019 Yokohama, Japan , 14th European Diabetes and Endocrinology Congress December 02-03, 2019 |Barcelona, Spain , 3rd Annual Congress on Diabetes and Its Complications December 04-05, 2019 Tokyo, Japan, 3rd Annual Congress on Diabetes and Its Complications December 04-05, 2019 Tokyo, Japan.

Track 11 :Endocrinology and Diabetes

Endocrinology is a perplexing investigation of the different hormones and their activities and disarranges in the body. Endocrine Glands are organs that make hormones. These are substances that control exercises in the body and effectively affect the digestion system, multiplication, nourishment retention and use, development and improvement and so on. Hormones likewise control the way a living being reacts to their environment and help by giving sufficient vitality to different capacities. Diabetes is brought about by diminished creation of insulin or by diminished capacity to utilize insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to utilize glucose. This hormone is fundamental for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can't utilize glucose for vitality in spite of the elevated amounts of glucose in the circulatory system. This causes the unreasonable thirst, pee, and appetite, which are the most widely recognized side effects of diabetes. The abundance sugar stays in the blood and is then evacuated by the kidneys. This sickness happens in a few structures, yet the most well-known are Type I Diabetes or Juvenile Onset Diabetes or Insulin-Dependent Diabetes Mellitus (IDDM), Type II or Non-Insulin Dependent Diabetes Mellitus (NIDDM), and Gestational.

Congenital adrenal hyperplasia (CAH)
Graves’ disease
Hypoglycaemia
Hyperthyroidism
Hypothyroidism
Osteoporosis

Related Conferences:

Track 12 :Public Health Challenges Of Diabetes

Public health protects and promotes the health of the people where they live. Public health professionals aim to prevent people living in communities from falling ill and create awareness among them to encourage healthy atmosphere. Vaccinating children to avoid spread of disease, educating them in terms of risk factors and preventive measures, developing nutritional programs etc. are carried out by people in public health departments. They also shed light on why few communities of people are more prone to a disease than others.

Related Conferences:

Track 13 : Nanotechnology For Diabetes Treatment

Nanotechnology holds a great deal of promise for the world of medicine. It is likely that some of the first truly revolutionary changes noticeable in our everyday lives will be brought about by nanomedicine. the possibilities of nanomedicine include Nano formulations for efficient drug delivery, smart drugs which only activate when needed, engineered microbes which produce human hormones, and even "Nano robots", which would move autonomously around the body acting as a boost, or a replacement, for our immune system, red blood cells, or many other biological systems. Whilst many of these applications of nanotechnology as a long way off, there is a great deal of active research into medical technology - much of which is not very far-fetched. This article explores the way in which nanotechnology could be used to effectively treat, and possibly cure, diabetes - in particular Type 1 diabetes.

Nanomedicine
Applications of Nanotechnology for Diabetes Management
Oral Insulin
Monitoring Glucose Levels
Potential Long-Term Treatments or Cures for Diabetes
Nano porous Immunoisolation Devices
Artificial Pancreas

Related Conferences:

Track 14 : Diabetic Nephropathy

Diabetic Nephropathy is the chronic loss of functioning of the kidneys occurring in those with diabetes. This is also known as End-Stage Renal Disease (ESRD). Not everyone with diabetes has kidney failure, around 40% of people with diabetes can develop nephropathy. Usual symptom is frequent urination, urine usually doesn’t contain protein albumin, but in some cases your kidneys are not able to filter the protein out the way they should and then the problem is diagnosed as diabetic nephropathy

Pathophysiology of Diabetic Nephropathy
Complications of Diabetic Nephropathy

Related Conferences:

Track 15 : Type 1 Diabetes & Type 2 Diabetes

Type 1 diabetes is a serious type of condition. It is also known as insulin-dependent diabetes. It's occasionally called "adolescent" diabetes, since Type 1 diabetes occurs more often in kids and young people. However, it can occur at any age. It is an autoimmune disease because the body’s immune system attacks its own pancreas and destroys its islet cells. These cells are responsible for producing insulin and maintaining the blood sugar levels in the body. Without insulin, the high sugars in the blood can damage eyes, nerves, heart, kidneys and other parts of the body.

Type 2 diabetes is a common condition that causes the level of sugar (glucose) in the blood to become too high. It can cause symptoms like excessive thirst, needing to pee a lot and tiredness. It can also increase your risk of getting serious problems with your eyes, heart and nerves. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups. It's caused by problems with a chemical in the body (hormone) called insulin. It's often linked to being overweight or inactive, or having a family history of type 2 diabetes.

Related Conferences:

14th European Diabetes and Endocrinology Congress December 02-03, 2019 |Barcelona, Spain , 3rd Annual Congress on Diabetes and Its Complications December 04-05, 2019 Tokyo, Japan, 13th International Conference on Endocrinology Diabetes and Metabolism April 08-09, 2019 Wellington, New Zealand, 12th World Congress on Endocrinology and Metabolic Disorders May 13-14th, 2019 Osaka, Japan , 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey , 21st Asia Pacific Diabetes Conference July 29-30, 2019 Perth, Australia , 4th International Conference & Exhibition on Metabolic Syndrome June 20-21, 2019 Paris, France, 18th Global Conference on Diabetes and Nursing Care June 27-28, 2019 Amsterdam, Netherlands, 12th World Congress on Diabetes, Endocrinology and Nursing July 05-06, 2019 Columbus, USA , 28th European Diabetes Congress July 17-18, 2019 Edinburgh, Scotland.

Track 16 :Thyroid Disorders

Thyroid malignancy is a metastatic tumour of the thyroid organ. It is similarly unprecedented contrasted with different tumours. Inside USA, it is figured that in 2016 near 64,000 new patients will be determined to have thyroid growth, contrasted with in excess of 240,000 patients with bosom malignancy and 135,000 patients with colorectal tumour. Be that as it may, less than 2,000 patients kick the bucket of thyroid tumour every year. In 2013 more than 630,000 patients were living with thyroid tumour inside USA. Ongoing epidemiological information from WHO recommends that there are in excess of 750 million cases all around with a thyroid issue. Expanding centre by government associations and private organizations like WHO and pharmaceutical organizations, to make consciousness of thyroid lack is fuelling the market development. Levothyroxine and Cytomel are the most offering drugs in the thyroid insufficiency treatment advertise. Take after Endocrinology Conferences and Diabetes Conferences for more updates.

Hormones and diabetes complications
Thyroid and thymus
Primary aldosterone’s
Hyperprolactinemia

Related Conferences:

Track 17: Endocrinology Disorders

The endocrine system is a system of organs that deliver and discharge hormones that assistance control numerous vital body capacities, including the body's capacity to change calories into vitality that forces cells and organs. The endocrine framework impacts how your heart pulsates, how your bones and tissues develop, even your capacity to make an infant. It assumes an indispensable part in regardless of whether you create diabetes, thyroid malady, development issue, sexual brokenness, and a large group of other hormone-related scatters.

Placental Endocrinology
Ovarian Disorders
Gestational Diabetes- Treatment and care
Low Testosterone
Hyperandrogenism in women
Endocrinology of fertility
Hormonal Changes and its effects

Related Conferences:

Track 18 : Advanced Technologies for the Treatment of Diabetes

The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace. come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed, regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.

New Discoveries and Emerging Therapies for Type 1 Diabetes
New Discovery and Treatment for Type 2 Diabetes
New Therapeutic Mechanisms for Diabetes
Other advanced medical technologies used in hospitals
Exploring novel therapies in diabetes treatment

Related Conferences:

Market analysis

Summary of Diabetes Asia Pacific 2019:

21^st Asia Pacific Diabetes Conference is among the World's leading Scientific Conference. The two day event on Diabetes will host 60+ Scientific and technical sessions and sub-sessions on cutting edge research and latest research innovations in the field of Diabetes and Endocrinology and relevant biomedical sciences across the globe. This year annual Diabetes Conference will comprises of 13 major sessions and 104 sub-sessions designed to offer comprehensive sessions that address current issues in Diabetes & Endocrinology, Pancreatic Disorders & Therapy, Steroids & Hormonal Science.

Importance & Scope:

Conference on Diabetes is focusing on various topics, which will target a higher number of audiences. This conference will provide a platform to broadcast the new advancements in the field of diabetes and endocrinology background. Diabetes conference will bring together academic and industrial professions, leading to a brand new experience. We all know it is easier to understand the research from the researcher and more helpful rather than reading it from the journal.

Why Sydney?

The exact number of people with diabetes in Australia is difficult to estimate, but it is likely that more than 1.1 million Australians are living with the disease. Type 2 diabetes accounts for approximately 85 per cent of people with diabetes. Approximately 12 per cent of Australians with diabetes are diagnosed with type 1 diabetes. Around 12 to 14 per cent of pregnant women will develop GDM. Diabetes has a significant, and often preventable, impact on the health and wellbeing of the Australian population. In 2011, diabetes was the underlying cause of 3 per cent of all deaths and an underlying or associated cause of 10 per cent of all deaths. There are a significant number of diabetes-related complications, many of which are preventable. They include heart attack, stroke, amputation, blindness, kidney failure, depression and nerve disease. Prediabetes was examined as part of the Australian Diabetes, Obesity and Lifestyle Study (AusDiab), which found that 16 per cent of adults over the age of 25 years — approximately 2.5 million people — have prediabetes . Between 15 and 30 per cent of people with prediabetes are likely to develop type 2 diabetes within five years. It is difficult to estimate the total economic and social impact of diabetes. Health care that is directly attributable to diabetes costs approximately $1.7 billion per year. In terms of indirect costs, the full cost of diabetes may be as high as $14 billion per year. These indirect costs include reduced productivity, absence from work, early retirement and premature death and bereavement. Costs are heavily concentrated in particular sub-groups of people with diabetes. Annual direct costs for people with diabetes complications are more than twice as much as for people without complications: $9600 compared with $3500

Conference Highlights

Diabetes Diagnostics and Therapeutics
Genetics and Gene Regulation
Risk Factors and Related Diseases of Diabetes
Pathophysiology Of Endocrine Glands And Hormones
Diabetic Surgeries
Clinical Research and Case Studies
Diabetic Nutrition & Physical Fitness
Gestational diabetes
Emerging Focus in Diabetes Research
Stem Cell treatment for Type 2 Diabetes
Endocrinology and Diabetes
Public Health Challenges of Diabetes
Nanotechnology for Diabetes Treatment
Diabetic Nephropathy
Type 1 Diabetes & Type 2 Diabetes
Thyroid Disorders
Endocrinology Disorders
Advanced Technologies for the Treatment of Diabetes

Major Diabetes Research Associations around Asia Pacific

Diabetes Australia Research Program
Juvenile Diabetes Research Foundation (JDRF)
The Australian Centre for Behavioural Research in Diabetes
The Diabetes Research Foundation Western Australia
The John Curtin School of Medical Research
The NHMRC Centre of Clinical Research Excellence on Clinical Science in Diabetes (Diabetes CCRE)
Baker
The Walter and Eliza Hall Institute of Medical Research
Diabetes Australia
Austrian Diabetes Association
Dietitians Association of Australia
Diabetes Association Brisbane
Canadian Diabetes Association in Sydney

Major Diabetes Research Associations around Globe

International Diabetes Federation
American Diabetes Association
Canadian Diabetes Association
Diabetes New Zealand
Diabetes United Kingdom
Glycosmedia
Diabetes Indian Association
Diabetes Australia
Austrian Diabetes Association
Diabetes UK
Diabetes South Africa
Spanish Diabetes Society (Spain)
Swedish Diabetes Association
Korean Diabetes Association

Target Audience:

Endocrinologists
Diabetologists
Researchers
Practitioners/Doctors
Students
Nurse educator
Podiatrist
Dietitian
Eye Doctors
Nephrologists
Physical trainer or Exercise physiologist

Major Universities on Diabetes Research

Albany Medical College
Baylor College of Medicine
Creighton University School of Medicine
Dartmouth Medical School
Florida International University College of Medicine
Georgetown University School of Medicine
Howard University College of Medicine
Harvard Medical School
Johns Hopkins University School of Medicine
Pennsylvania State University College of Medicine

Past Conference Report

Diabetes Asia Pacific 2018

Diabetes Asia Pacific 2018 Report

20^th Asia Pacific Diabetes Conference (Diabetes Asia Pacific 2018) convoked by Conference Series LLC during July 16-17, 2018 which was successfully held at Mercure Sydney, Australia with a theme “Therapeutic Approaches for Diabetes Management and Endocrine Complications” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

This one-stop meeting provided comprehensive updates, education, and information on current and emerging Diabetic issues and challenges.

The pragmatic meet organized by Conference Series LLC brought together a group of diagnostic therapists, physicians, academic scientists, industry researchers, scholars, decision makers, public health professionals and other health care professionals from across the globe with interest and expertise in the field of diabetes research. The conference marked the successful gathering of eminent speakers from various reputed organizations driving the two day event into the path of success and their regnant talks enlightened the gathering.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus)
Influence of genetics on Diabetes
Metabolic Syndrome / Syndrome X
Cellular and Molecular Endocrinology
Endocrine complications
Insulin- Important Pancreatic hormone
Diabetic Kidney Disease (Diabetic Nephropathy)
Diabetic Eye Disease (Diabetic Retinopathy)
Complications of Diabetes
Diabetic Transplantations
Important Tests to Diagnose Diabetes
Management of Diabetes
Diabetes Oral Medications/Anti-Diabetic Medications
Approaches and technologies for the Treatment of Diabetes
New Diabetes Treatments-Enhanced blood flow
Endocrine system and metabolic diseases
Adrenomyeloneuropathy- Rare Genetic Disease

Diabetes Asia Pacific 2018 Organizing Committee would like to thank the Moderator of the conference, Thi Phuong Lan Nguyen, Queensland University of Technology, Australia who contributed a lot for the smooth functioning of this event.

Diabetes Asia Pacific 2018 extends its warm gratitude to all the Honorable Guests and Keynote Speakers of the event:

Emilio Galea, Urgo International, United Arab Emirates
Irina Kurnikova, RUDN University, Russia
Joseph M Pappachan , University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom.
Gerald C. Hsu, eclaireMD Foundation, USA
Mohammad Saifuddin, Abdul Malek Ukil Medical College, Bangladesh

Conference Series LLC is privileged to felicitate Diabetes Asia Pacific 2018 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. Conference Series LLC would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.

With the valuable feedback received from the participants of Diabetes Asia Pacific 2018, Conference Series LLC is glad to announce the commencement of “21th Asia Pacific Diabetes Conference” to be held during July 13-14, 2019 Auckland, Newzealand. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing diabetes and its concomitant risk factors.

Past Reports Gallery